Neurocrine Biosciences
NBIX
#1221
Rank
NZ$26.78 B
Marketcap
$264.58
Share price
-0.46%
Change (1 day)
12.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company